Shaanxi Buchang Pharmaceutical Co., Ltd., a subsidiary of Buchang Group, was founded in 1993 and is a high-tech health industry group integrating pharmaceutical research/production/sales and diagnosis and treatment services
Buchang Pharmaceutical is a well-known domestic high-tech health industry company integrating pharmaceutical research, production and sales, with more than 6,000 employees. After more than ten years of development, the company has become a high-quality and professional team. It has improved 10 business divisions and more than 10 pharmaceutical factories.
Buchang's business started in 1993, after more than ten years of hard work, has developed into a pharmaceutical industry, while involved in high-tech industry, health industry and many other fields, diversified business cluster. Its pharmaceutical sector "Buchang Pharmaceutical" is a well-known domestic enterprise focusing on the research and development, production and sales of traditional Chinese medicine patented drugs, with production bases in Shandong, Shaanxi and Hebei, and branches in major provinces in China. After years of development, the company has built a high-quality, professional team, with ten business divisions, more than ten pharmaceutical factories, and a sales network covering all parts of the country.
Buchang Pharmaceutical will take "modernization of traditional Chinese medicine and internationalization of the market" as its own responsibility, strive to build the first brand of traditional Chinese medicine in China, and continue to contribute to the health of the Chinese people!
In more than ten years of development, the company has always put the political concept of "listening to the party, taking the socialist road, respecting the leaders of governments at all levels, and operating in accordance with the law" in the first place, adhering to the image concept of "professional quality and health messenger", taking "a century-old enterprise" as the development goal, and adhering to the "market-centered, anxious about the market, thinking about what the market thinks" in the process of operation, and has formed the brand concept of "three products in one" (entrepreneur brand, enterprise brand, product brand). Its unique and advanced corporate culture has become an important force for the rapid development of the enterprise.
Since 1997, Buchang Pharmaceutical has been rated as the first private enterprise in Shaanxi Province for many years, and by the end of 2015, it has paid more than 10 billion yuan in taxes for the country. In December 2002, Buchang Pharmaceutical was rated as "Honest Tax Paying Enterprise" by the State Administration of Taxation and the All-China Federation of Industry and Commerce. In 2006, Buchang Pharmaceutical was awarded the "Top Ten Most Growing Enterprises in China's Pharmaceutical Industry". In June 2007, Buchang Pharmaceutical was awarded the "People's Assured Medicine Enterprise", and Buchang Danhong Injection was awarded the honor of "People's Assured Medicine". In August 2007, Buchang Pharmaceutical won the "Golden Spectrum Award", the highest annual award in the China General Evaluation List of Pharmaceutical Brands, which is one of the top ten brands of Chinese pharmaceutical enterprises. In 2008, Buchang Pharmaceutical ranked 17th in the list of China's top 100 pharmaceutical industries. In March 2008, Professor Zhao Buchang, the founder of Buchang Pharmaceutical, was elected as a representative of the 11th National People's Congress, and Zhao Chao, President of Buchang Pharmaceutical, was elected as a representative of the 11th National People's Congress.
Buchang Pharmaceutical has always attached great importance to scientific research and product development, spent huge sums of money on scientific research and product development, adhered to the road of independent research and development, and has more than 50 exclusive intellectual property products. The chairman and president have formulated high, medium, low, long, medium and short product development strategies for the company. Continuously launched Naoxintong series products and other high-tech products, such as "Buchang Wenxin Granules", "Buchang Beitong Danhong Injection" and so on. The business scope covers cardiovascular and cerebrovascular disease drugs, anti-tumor pure Chinese medicine injections, gynecological drugs, digestive products, general medicines, Western medicines, and OTC products. A number of GAP planting bases, strong product reserves, market networks and advanced corporate culture constitute the core competitiveness of Buchang. In 2008, Buchang Pharmaceutical was awarded the "2007 China Top 100 Commercial Science and Technology Enterprises". In June of the same year, Buchang Pharmaceutical was awarded the honorary title of "2008 China's Top 500 Private Technology Enterprises". Its representative product "Buchang Brain Heart" has won: the 42nd World Invention Exposition Eureka Gold Award; "Consumer Trustworthy Product" awarded by China Consumer Protection Foundation; In 2004, it was elected as the "No. 1 Brand of Choice for Product Quality and Customer Satisfaction in China's Cardiovascular and Cerebrovascular Drug Market".
Focusing on the research and development of high-tech new drugs is Buchang's general scientific research and development idea in recent years. For example, biopharmaceutical, purification technology of traditional Chinese medicine monomers, Parker process technology of drugs and research and development of cephalosporin antibiotic intermediates, etc., are all fields involved in the company's pharmaceutical industry. The success of these aspects will accelerate the internationalization of Buchang and consolidate the foundation of the century-old Buchang foundation.
Buchang Pharmaceutical adheres to the principle of "integrity-based, steady operation", pays attention to product quality, and proposes that "efficacy is the last word" in strict accordance with the national GAP and GMP standards for planting and production, and strictly controls the quality, which has won wide praise for the company.
